Insulin Secretion Modelling to Characterize Post‐Bariatric Hypoglycaemia After Roux‐en‐Y Gastric Bypass
Abstract
ABSTRACT Aim Roux‐en‐Y Gastric Bypass (RYGB) is an effective treatment for obesity and Type 2 diabetes. Some individuals develop postprandial hypoglycaemia, termed post‐bariatric hypoglycaemia (PBH). PBH is associated with marked postprandial increases in incretin and insulin levels. This study investigates how insulin secretion differs between post‐RYGB patients with and without hypoglycaemia by identifying key secretion parameters. Methods Insulin secretion was modelled using plasma glucose, insulin and C‐peptide concentration data obtained from mixed meal tolerance test in three cohorts: healthy individuals without a history of upper gastrointestinal surgery (controls, n = 11), post‐RYGB individuals without hypoglycaemia (RYGB‐non‐hypo, n = 18) and post‐RYGB individuals with hypoglycaemia (RYGB‐PBH, n = 20). Results Meal‐driven insulin secretion differed across groups ( p = 0.008) and was significantly higher in RYGB‐PBH than controls (0.23 vs. 0.14 pmol/mg, p = 0.006), but not in RYGB‐non‐hypo (0.22, p = 0.071). Glucose‐driven insulin secretion decreased in RYGB‐non‐hypo (0.04 vs. 0.07 pmol/kg/min per mg/dL, p = 0.005) but did not differ from controls in RYGB‐PBH (0.08, p = 0.948), differing significantly between the two post‐RYGB groups ( p < 0.001). Meal absorption was significantly faster in both post‐RYGB groups (9.08 and 8.44 vs. 11.48 min, both p < 0.001). Models fit plasma insulin and C‐peptide well (mean joint nRMSE: 0.60–0.92 across groups). Parameters were estimated with good precision (CV < 100%). Conclusions Insulin secretion dynamics differ between post‐RYGB patients with and without hypoglycaemia. Both groups showed faster meal absorption and a shift towards higher meal‐driven secretion, significant only in RYGB‐PBH, but only those without hypoglycaemia showed a reduction in glucose‐driven secretion. This PBH model can support in silico development of glucagon‐based interventions.